Development is significant step toward skin grafts that can be integrated into patient’s skin
Researchers at Rensselaer Polytechnic Institute have developed a way to 3D print living skin, complete with blood vessels. The advancement, published online today in Tissue Engineering Part A, is a significant step toward creating grafts that are more like the skin our bodies produce naturally.
“Right now, whatever is available as a clinical product is more like a fancy Band-Aid,” said Pankaj Karande, an associate professor of chemical and biological engineering and member of the Center for Biotechnology and Interdisciplinary Studies (CBIS), who led this research at Rensselaer. “It provides some accelerated wound healing, but eventually it just falls off; it never really integrates with the host cells.”
A significant barrier to that integration has been the absence of a functioning vascular system in the skin grafts.
Karande has been working on this challenge for several years, previously publishing one of the first papers showing that researchers could take two types of living human cells, make them into “bio-inks,” and print them into a skin-like structure. Since then, he and his team have been working with researchers from Yale School of Medicine to incorporate vasculature.
In this paper, the researchers show that if they add key elements — including human endothelial cells, which line the inside of blood vessels, and human pericyte cells, which wrap around the endothelial cells — with animal collagen and other structural cells typically found in a skin graft, the cells start communicating and forming a biologically relevant vascular structure within the span of a few weeks.
Watch Karande explain this development:
“As engineers working to recreate biology, we’ve always appreciated and been aware of the fact that biology is far more complex than the simple systems we make in the lab,” Karande said. “We were pleasantly surprised to find that, once we start approaching that complexity, biology takes over and starts getting closer and closer to what exists in nature.”
Once the Yale team grafted it onto a special type of mouse, the vessels from the skin printed by the Rensselaer team began to communicate and connect with the mouse’s own vessels.
“That’s extremely important, because we know there is actually a transfer of blood and nutrients to the graft which is keeping the graft alive,” Karande said.
In order to make this usable at a clinical level, researchers need to be able to edit the donor cells using something like the CRISPR technology, so that the vessels can integrate and be accepted by the patient’s body.
“We are still not at that step, but we are one step closer,” Karande said.
“This significant development highlights the vast potential of 3D bioprinting in precision medicine, where solutions can be tailored to specific situations and eventually to individuals,” said Deepak Vashishth, the director CBIS. “This is a perfect example of how engineers at Rensselaer are solving challenges related to human health.”
Karande said more work will need to be done to address the challenges associated with burn patients, which include the loss of nerve and vascular endings. But the grafts his team has created bring researchers closer to helping people with more discrete issues, like diabetic or pressure ulcers.
“For those patients, these would be perfect, because ulcers usually appear at distinct locations on the body and can be addressed with smaller pieces of skin,” Karande said. “Wound healing typically takes longer in diabetic patients, and this could also help to accelerate that process.”
The Latest on: 3D bioprinting
via Google News
The Latest on: 3D bioprinting
- The Case Against Tarveda: An Open Letter to Organovo Shareholderson January 21, 2020 at 4:00 am
Their interest in Organovo is driven by an interest in 3D bioprinting, and in fact they specifically run a fund focused on 3D printing. In their offices in New York City, a very large bull statue sits ...
- 3D Bioprinting Market 2020 Upcoming Trends, Share, Top manufactures analysis, Demand, Growth Drivers, and Future Outlook to 2029on January 17, 2020 at 7:26 am
Reportocean.com adds has announced the new market intelligence report on “3D Bioprinting Market 2020 Upcoming Trends, Share, Top manufactures analysis, Demand, growth, and Future Outlook to 2029” The ...
- Success: 3D Bioprinter in Space Prints With Human Heart Cellson January 15, 2020 at 4:30 am
While the 3D printer’s bio-ink contained cell types such as heart muscle cells, nerve cells and vascular cells, it notably did not contain the scaffolding materials or thickening agents normally ...
- 3D Systems Joins CollPlant in Regenerative Medicine Effortson January 14, 2020 at 7:53 am
3D Systems DDD recently partnered with CollPlant Biotechnologies CLGN to jointly develop tissue and scaffold bioprinting processes for third party companies, aiming to expedite the advancements in the ...
- 3D Systems teams with CollPlant on 3D bioprinting solutionson January 13, 2020 at 7:02 am
3D Systems has announced a collaboration with CollPlant Biotechnologies, a regenerative medicine company focused on 3D bioprinting of tissues and organs, to jointly develop tissue and scaffold ...
- We are one step closer to 3D printing donor organs in outer spaceon January 10, 2020 at 9:50 am
You might call it a giant leap for 3D bioprinting: Human heart cells have been 3D printed on the International Space Station (ISS) and are making their way back to Earth this week inside a SpaceX ...
- 3D Bioprinting Industry Study, 2019-2025 - Leading Players are Organovo Holdings, 3D Systems, CELLINK, Stratasys, and CollPlanton January 10, 2020 at 6:42 am
DUBLIN, Jan. 10, 2020 /PRNewswire/ -- The "Global 3D Bioprinting Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The global 3D bioprinting market is anticipated to grow ...
- 3D Cell Culture Market to Witness Robust Expansion by 2030 with Prominent Key Players: Lonza, 3D Biotek , Corning Incorporatedon January 10, 2020 at 1:43 am
On the basis of product, the 3D cell culture market is segmented into scaffold-based 3D cell culture, scaffold-free cell culture, magnetic levitation & 3D bioprinting, and microfluidics-based 3D cell ...
- Aspect Biosystems raises $26 million CAD in Series A for 3D printing of human tissueson January 9, 2020 at 5:10 am
Aspect Biosystems, a biotechnology company that conducts 3D bioprinting of human tissues, has raised $26 million CAD ($20 million USD) for its Series A round of funding. The new capital marks the ...
- Aspect Biosystems Announces US $20 Million Series A Financing to Advance Its Leading Platform for 3D Bioprinting of Human Tissueon January 9, 2020 at 4:00 am
VANCOUVER, British Columbia--(BUSINESS WIRE)--Aspect Biosystems (“Aspect”) (“the Company”), a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, today announced a US $20 ...
via Bing News